Tergynan warnings
Warnings are a mix of Precautions. Contraindications and interactions and serious harmful effects associated with the medicine intake. A diabetic or Hypertensive patient need to be warned about few drug interactions. A known hypersensitivity patient needs to be careful about the reactions or anaphylactic shock. A pregnant woman or a breastfeeding woman should be warned of certain medications. A Hepatitis [liver disease] patient or a cardiac patient should avoid few drugs.Related to Metronidazole (Tergynan):
Treatment with Metronidazole (Tergynan) should not be prescribed for more than 10 days and must not be repeated more than 2 to 3 times per year.
Discontinue treatment if local intolerance or allergic reaction or if signs such as dizziness, mental confusion, ataxia appear.
Consider the risk of worsening of neurological status in patients with central and peripheral neurological disorders severe, chronic or progressive.
It is best to restrain the taking of alcoholic drinks during therapy (antabuse effect).
Related to Neomycin (Tergynan):
The awareness of topical antibiotic may compromise the future use by the general route of the same antibiotic or related antibiotics.
Pregnancy:
Given the presence in this specialty of an aminoglycoside, Neomycin (Tergynan), causing a risk of ototoxicity and the possible systemic passage, the use of this medicine in pregnant women is recommended.
Breastfeeding:
In the absence of data on the passage of this drug in breast milk, the use of this drug should be avoided.
References
- DailyMed. "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "PREDNISOLONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
